Clinical Trial Update: Phase 2 Study in Vascular Inflammation on Patients After an Acute Coronary Syndrome Event [Phase 2]

View source ↗

Summary

A Phase 2 trial conducted by Tallikut Pharmaceuticals evaluated an investigational drug for vascular inflammation in patients after an acute coronary syndrome e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Snippet

Sponsor: Tallikut Pharmaceuticals, Inc. | Conditions: Acute Coronary Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2013-08-09